Sangamo Therapeutics
SGMO
#9330
Rank
โ‚น10.03 B
Marketcap
โ‚น24.23
Share price
-2.96%
Change (1 day)
-59.93%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -โ‚น9.46 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are โ‚น32.87 Million. In 2024 the company made an earning of -โ‚น9.11 Billion, an increase over its 2023 earnings that were of -โ‚น11.01 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น9.46 Billion3.81%
2024 -โ‚น9.11 Billion-17.27%
2023 -โ‚น11.01 Billion-40.88%
2022 -โ‚น18.62 Billion9.79%
2021 -โ‚น16.96 Billion41.52%
2020 -โ‚น11.99 Billion23.17%
2019 -โ‚น9.73 Billion36.33%
2018 -โ‚น7.14 Billion36.89%
2017 -โ‚น5.22 Billion-22.32%
2016 -โ‚น6.71 Billion54.86%
2015 -โ‚น4.34 Billion75.62%
2014 -โ‚น2.47 Billion0.13%
2013 -โ‚น2.47 Billion
2011 -โ‚น3.32 Billion43.66%
2010 -โ‚น2.31 Billion28.52%
2009 -โ‚น1.8 Billion-23.55%
2008 -โ‚น2.35 Billion2.45%
2007 -โ‚น2.3 Billion19.5%
2006 -โ‚น1.92 Billion50.78%
2005 -โ‚น1.28 Billion75%
2004 -โ‚น0.73 Billion-33.25%
2003 -โ‚น1.09 Billion-62.27%
2002 -โ‚น2.89 Billion102.82%
2001 -โ‚น1.43 Billion23.21%
2000 -โ‚น1.16 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น3.102 T-30,874.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น830.04 B-8,332.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น143.93 B-1,527.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-โ‚น232.21 Billion 2,203.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น905.96 B-9,085.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น2.073 T-20,666.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น53.24 B-628.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น44.61 B-542.54%๐Ÿ‡บ๐Ÿ‡ธ USA